Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Stromal Tumors × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 33 Neoplasms, Plasma Cell 10 Prostatic Neoplasms 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1 Melanoma 1

Interventions

Sunitinib 14 Imatinib Mesylate 12 nilotinib 7 ripretinib 3 regorafenib 3 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3 pexidartinib 2 pembrolizumab 2 avapritinib 2 Bevacizumab 2 trametinib 1 spartalizumab 1 romidepsin 1 ponatinib 1 pazopanib 1 palbociclib 1 olaratumab 1 guadecitabine 1 ferric carboxymaltose 1 epacadostat 1 dabrafenib 1 cediranib 1 Surveys and Questionnaires 1 Sorafenib 1 Observation 1 Iron-Dextran Complex 1 Indocyanine Green 1 Immunoglobulin G 1 HhAntag691 1 Fluorescein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡